SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

____________________
 

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No.1)*

NovaMed Inc
___________________________________________________________
(Name of Issuer)
 
 

COMMON STOCK
___________________________________________________________
(Title of Class of Securities)

66986W207

______________________________

(CUSIP Number)
 

May 31, 2010

___________________________________________________________
(Date of Event Which Requires Filing of this Statement)
 
 

Check the appropriate box to designate the Rule pursuant to which this Schedule is filed:
 

[X]     Rule 13d – 1(b)
[ ]     Rule 13d – 1(c)
[ ]     Rule 13d – 1(d)
 

*     The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes .)


CUSIP No 66986W207

13G

Page 2 of 6 Pages

1

NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY):

 
Bank of America Corporation                          56-0906609

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)                                        (a) [ ]

                                        (b) [ ]

3

SEC USE ONLY

4

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

5 SOLE VOTING POWER

 

6 SHARED VOTING POWER

 

7 SOLE DISPOSITIVE POWER

 

8 SHARED DISPOSITIVE POWER

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

[ ]

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 

Less than 5% (closing filing)

12

TYPE OF REPORTING PERSON (See Instructions)

HC


Item 1(a).     Name of Issuer:

NovaMed Inc

Item 1( b ).     Address of Issuer’s Principal Executive Offices:

980 N Michigan Avenue , Suite 1620
Chicago, IL 60611

          

Item 2 ( a ).     Name of Person Filing:

Bank of America Corporation

Item 2 ( b ).      Address of Principal Business Office or, if None, Residence:

100 North Tryon Street, Floor 25

Bank of America Corporate Center

Charlotte, NC 28255

Item 2 ( c ).      Citizenship :

Delaware

 

Item 2 ( d ).      Title of Class of Securities:

Common Stock


Item 2 ( e ).      CUSIP Number:

66986W207

Item 3.           If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c),

Check Whether the Person Filing is a:

(a)     

[ ] Broker or dealer registered under Section 15 of the Exchange Act.


(b)     

[ ] Bank as defined in Section 3(a)(6) of the Exchange Act.

(c)     

[ ] Insurance company as defined in Section 3(a)(19) of the Exchange Act.


(d)     

[ ] Investment company registered under Section 8 of the Investment Company Act.


(e)     

[ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).


(f)     

[ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).


(g)     

[X] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).

(h)     

[ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.

(i)     

[ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act.

(j)     

[ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

If this statement is filed pursuant to Rule 13d-1(c), check this box. [ ]

Item 4.           Ownership:

With respect to the beneficial ownership of the reporting person, see Items 5 through 11 of the cover pages to this Schedule 13G, which are incorporated herein by reference.

Item 5.           Ownership of 5 Percent or Less of a Class:

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ X ].

Item 6.           Ownership or More than Five Percent on Behalf of Another Person :

Not Applicable.


Item 7.          Identification and Classification of the Subsidiary Which Acquired the

Security Being Reported on by the Parent Holding Company or Control
Person
:

With respect to the beneficial ownership of the reporting person, see Items 5 through 11 of the cover pages to this Schedule 13G, which are incorporated herein by reference.

Item 8.           Identification and Classification of Members of the Group :

Not Applicable.

Item 9.           Notice of Dissolution of Group :

Not Applicable.


Item 10.     Certification:

By signing below each of the undersigned certifies that, to the best of such undersigned’s knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE
 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated:      June 10, 2010
 

Bank of America Corporation

By:       /s/ Angelina L Richardson
     _____________________

/s/ Angelina L Richardson

Vice President

Novamed (MM) (NASDAQ:NOVAD)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Novamed (MM) Charts.
Novamed (MM) (NASDAQ:NOVAD)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Novamed (MM) Charts.